Anemia is a major public health problem in many areas of Southeast Asia. Ascertaining anemia and defining its underlying causes is essential for providing appropriate care, management, and establishment of a control program. Limited studies on these have been carried out on people living at the borders of Thailand, Lao PDR, and Cambodia. This cross-sectional study was done in four areas along the borders of Thailand, Lao PDR, and Cambodia. Blood specimens were collected from subjects aged 15–18 years in four districts including Kantharalak, Si Sa Ket province (n = 36), Nam Khun (n = 109), Nam Yuen (n = 98), and Na Chaluai (n = 128), Ubon Ratchathani province, Thailand. RBC parameters were recorded, and serum ferritin (SF) level was measured. Diagnosis of thalassemia and hemoglobinopathies was based on hemoglobin (Hb) and DNA analyses. Measurement of C-reactive protein was performed to exclude false-negative result of iron deficiency. The prevalence of anemia was found to be 25.1%. ID accounted for only 10.5%. Various types of thalassemia were identified in 67.7% of the subjects. The overall prevalence of thalassemia included 3.5% α⁰-thalassemia, 0.8% β-thalassemia, 47.7% Hb E, and 53.6% α⁺-thalassemia. The proportions of ID, thalassemia and combined ID and thalassemia among anemic subjects were 6.5%, 66.6%, and 20.4%, respectively. The results indicate that thalassemia and hemoglobinopathies rather than ID are major causes of anemia in Thailand-Lao PDR-Cambodia triangle. This information should prove useful for implementing an anemia control program in the regions.

Major depressive disorder (MDD) is a global health concern with a complex etiology involving genetic, environmental and infectious factors. The exact cause of MDD remains unknown. The present study explored the association between genetic factors, human herpesvirus 6 (HHV‑6) and MDD. The present study analyzed single nucleotide polymorphisms (SNPs) and HHV‑6 viral load in oral buccal samples from patients with MDD (with and without blood relatives with MDD) and healthy controls. The study used high‑resolution melt analysis to examine rs40184 (C>T) in the solute carrier family 6 member 3 (SLC6A31) gene, rs6265 (C>T) in the brain‑derived neurotrophic factor (BDNF) gene and rs9383046 (G>A) in the jumonji and AT‑rich interaction domain‑containing 2 (JARID2) gene. HHV‑6 infection and viral load was assessed using the quantitative PCR. Whole‑exome sequencing was used to examine SNPs. The variant alleles of SNPs rs40184 [18/40 (45.00) vs. 29/238 (12.55%)] and rs6265 [30/54 (55.46) vs. 117/292 (40.06%)] were significantly more common in patients with MDD than in healthy controls, indicating they may be probable hereditary risk factors for MDD. HHV‑6 positivity was significantly more common in carriers of the G/A genotype (12/15, 80%) than carriers of the G/G genotype (75/363, 20.7%) for rs9383046, implying that genetic variations may affect HHV‑6 risk and MDD onset. Similarly, HHV‑6 viral loads were significantly higher in carriers of the G/A genotype (99,990.85±118,392.64 copies/ng DNA) than carriers of the G/G genotype (48,249.30±101,216.28 copies/ng DNA) for rs9383046. Whole‑exome sequencing identified two SNPs in JARID2 (rs11757092 and rs9383050) associated with MDD, highlighting its genetic complexity. The present study helps explain the complex interactions between HHV‑6 infection, genetics and MDD onset, improving understanding of how SNPs in JARID2 contribute to HHV‑6 infection and MDD onset; these findings may impact future approaches to diagnosing and treating MDD.

Long COVID is characterized by persistent symptoms associated with chronic inflammation and oxidative stress. While high-intensity interval training (HIIT) and supplementation with antioxidants such as Triphala have demonstrated individual therapeutic benefits, their combined effects remain unclear. This study aimed primarily to evaluate the effects of an 8-week HIIT program on markers of inflammation, oxidative stress, and exercise-related symptoms in individuals with long COVID, and secondarily to explore whether Triphala supplementation provided additional benefits. A total of 104 participants (aged 18–59 years) were randomized into three groups—control (placebo), HIIT (cycling for 28 min/day, 3 days/week), and combined (HIIT + Triphala, 1000 mg/day)—for 8 weeks. The biomarkers assessed included interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), malondialdehyde (MDA), protein carbonyls, and superoxide dismutase (SOD) activity. Following the intervention, significant reductions in IFN-γ, TNF-α, MDA, protein carbonyls, and rating of perceived exertion were observed in both the HIIT and combined groups (p < 0.05), with no significant differences between the two. SOD activity significantly increased in all groups, including the control group (p < 0.05), with no between-group differences. An 8-week HIIT program appears to be effective in reducing inflammation, oxidative stress, and dyspnea in individuals with long COVID. Triphala supplementation did not provide any additional statistically significant benefit but was safe and well tolerated.

Excess adiposity is associated with increased oxidative stress and inflammation, which contribute to metabolic dysregulation. Both exercise training and bioactive plant-derived compounds have been explored as therapeutic strategies to mitigate these effects. Asparagus (Asparagus officinalis L.) root extract, rich in ecdysteroids such as 20-hydroxyecdysone (20E), exhibits potent antioxidant and anti-inflammatory activities. This randomized controlled trial investigated the combined effects of high-intensity interval training (HIIT) and asparagus root extract (ARE) supplementation on metabolic parameters, oxidative stress, inflammatory biomarkers, and white blood cell counts in overweight and obese adults. Seventy-two participants aged 18–30 years with a body mass index ≥ 23 kg/m² were randomly assigned to one of four groups: control (CON), ARE supplementation only (ARE), HIIT only (HIIT), and combined intervention (COM). The HIIT protocol comprised a modified Tabata regimen of progressive bodyweight intervals at 80–90% and 40–50% of maximal perceived exertion, performed three times per week for 12 weeks. Participants in the ARE and COM groups received a daily oral dose of ARE providing 1.71 ± 0.24 mg/kg/day of 20E. Compared with the CON group, the HIIT group showed significant reductions in total cholesterol (TC), the TC/high-density lipoprotein cholesterol (HDLC) ratio, and blood glucose levels, alongside significant increases in HDLC and superoxide dismutase (SOD) activity (all p < 0.05). The COM group demonstrated significant decreases in protein carbonyls and interleukin-6 levels and in the TC/HDLC ratio (all p < 0.05) as well as a significant increase in SOD activity (p = 0.002). The ARE group, meanwhile, exhibited significant increases in both SOD activity (p < 0.001) and malondialdehyde levels (p = 0.017). These findings suggest that combining HIIT with ARE supplementation produces synergistic improvements in oxidative and inflammatory status, whereas HIIT alone primarily enhances metabolic regulation in overweight and obese individuals.

Lactic Acid Bacteria (LAB)-derived antimicrobial compounds are recognized as a promising source of novel antimicrobial agents, particularly for the treatment of Methicillin-Resistant Staphylococcus aureus (MRSA), where the mode of action and associated cellular effects remain largely unexplored. This study aims to evaluate antibacterial activity of Limosilactobacillus fermentum YTPP05 isolated from pickled radish against MRSA. Upon the initial antibacterial evaluations, it was found that strain YTPP05 inhibited the growth of MRSA isolates. Multiplex PCR identified multiple resistance genes in our MRSA strains, including mecA, blaZ, and aacA genes, aligning with antibacterial susceptibility profiles determined by the disc diffusion assay. An agar overlay assay showed that YTPP05 possessed antibacterial potential, with the largest inhibition zone diameters of 40.83 ± 8.43 mm, while the inhibition zones of the Cell Free Supernatant (CFS) of YTPP05 by an agar well diffusion were 27.16 ± 2.93 mm against the MRSA isolates. The minimum inhibitory concentration and minimum bactericidal concentration of YTPP05-derived CFS were 125 mg/mL. Scanning Electron Microscopy (SEM) demonstrated YTPP05 extracts caused cell membrane disruption, bubble-like protrusion, and cell lysis. Collectively, this study highlights the anti-MRSA potential of YTPP05 as an alternative antimicrobial agent for combating MRSA infections.